Skip to main content
Intermediate Technical IVT

biochemical monitoring

Serial measurement of tumor markers and hormones to assess treatment response and disease progression in endocrine tumors.

Full Definition

Biochemical monitoring involves systematic tracking of specific biomarkers, tumor markers, and hormone levels to evaluate treatment efficacy and detect disease recurrence in endocrine malignancies. Key parameters include chromogranin A and specific hormones in functional NETs, calcitonin and CEA in medullary thyroid carcinoma, and catecholamine metabolites in pheochromocytoma. The frequency and selection of markers depend on tumor type, treatment modality, and clinical context. Biochemical responses may precede radiological changes and provide early indicators of therapeutic success or resistance. Interpretation requires understanding of marker limitations and potential confounding factors.

Usage

Usage note: Specify which markers are being monitored for clarity.

In Context

  • "Biochemical monitoring showed declining chromogranin A levels following initiation of somatostatin analog therapy." — Follow-up assessment
  • "Rising calcitonin on biochemical monitoring prompted imaging to assess for recurrent medullary thyroid carcinoma." — Surveillance protocol

Also known as

biomarker surveillance hormonal monitoring tumor marker tracking

Contrasted with

imaging surveillance clinical monitoring

Don't confuse with

laboratory screening diagnostic testing

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON